High cost inflation and rising interest rates have impacted consumer confidence and weakened consumers’ expectations of their own economy. Nevertheless, the increased economic uncertainty did not affect the pharmaceutical market, which continued to grow steadily in the second quarter in Sweden and Finland.
The availability of raw materials for pharmaceuticals slightly improved during the second quarter but the tight situation persists, and has affected the availability of some medicines in Sweden and Finland. Energy and fuel prices have stabilised.
As published in the Half-Year Report 2023 on 21 July 2023.